Search - tctmd.com

Displaying 181 - 200 of 595

Sort: Relevancy | Date

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Yael L. Maxwell

May 12, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

Michael O'Riordan

May 03, 2022

News Daily News

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

Yael L. Maxwell

April 22, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

Advertisement

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

To Save a Dying Mother

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Good News and Bad for High-Intensity Statin Use in ASCVD

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

More Evidence Links Breast Arterial Calcification and CVD Risk

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content